SGFE.F Stock Overview

Provides contract development and manufacturing of active pharmaceutical ingredients (API) and finished dosage forms to the pharmaceutical industry worldwide. More details

SGFE.F fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	1/6
Past Performance	2/6
Financial Health	4/6
Dividends	0/6

Rewards

Price-To-Earnings ratio (36.3x) is below the Life Sciences industry average (38.3x)

Earnings are forecast to grow 13.58% per year

Risk Analysis

Shares are highly illiquid

Has a high level of debt

My Notes

Capture your thoughts, links and company narrative

Siegfried Holding AG Competitors

Stevanato Group

NYSE:STVN

US$6.1b

Syneos Health

NasdaqGS:SYNH

US$4.5b

Sotera Health

NasdaqGS:SHC

US$3.7b

Bruker

NasdaqGS:BRKR

US$8.4b

Price History & Performance

Summary of share price highs, lows and changes for Siegfried Holding
Historical stock prices
Current Share Price	CHF 965.00
52 Week High	CHF 1,001.00
52 Week Low	CHF 837.50
Beta	0.67
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	446.27%

Recent updates

Shareholder Returns

	SGFE.F	US Life Sciences	US Market
7D	0%	-3.7%	-3.5%
1Y	n/a	-6.6%	22.1%

Return vs Industry: Insufficient data to determine how SGFE.F performed against the US Life Sciences industry.

Return vs Market: Insufficient data to determine how SGFE.F performed against the US Market.

Price Volatility

Is SGFE.F's price volatile compared to industry and market?
SGFE.F volatility
SGFE.F Average Weekly Movement	n/a
Life Sciences Industry Average Movement	9.6%
Market Average Movement	6.3%
10% most volatile stocks in US Market	17.0%
10% least volatile stocks in US Market	3.1%

Stable Share Price: SGFE.F has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine SGFE.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1873	3,797	Reto Suter	www.siegfried.ch

Siegfried Holding AG, together with its subsidiaries, provides contract development and manufacturing of active pharmaceutical ingredients (API) and finished dosage forms to the pharmaceutical industry worldwide. It offers pharmaceutical and analytical development, process and analytical transfer, commercial manufacturing and packaging, and scale-up and clinical trial material production services. The company develops and produces APIs and intermediates, as well as finished dosage forms, including solid oral dosage forms, sterile and aseptic filling injectables, ophthalmics, and inhalative products.

Siegfried Holding AG Fundamentals Summary

How do Siegfried Holding's earnings and revenue compare to its market cap?
SGFE.F fundamental statistics
Market cap	US$5.52b
Earnings (TTM)	US$152.13m
Revenue (TTM)	US$1.52b

36.3x

P/E Ratio

3.6x

P/S Ratio

Is SGFE.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SGFE.F income statement (TTM)
Revenue	CHF 1.28b
Cost of Revenue	CHF 952.10m
Gross Profit	CHF 332.25m
Other Expenses	CHF 203.38m
Earnings	CHF 128.86m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Feb 18, 2025

Earnings per share (EPS)	30.04
Gross Margin	25.87%
Net Profit Margin	10.03%
Debt/Equity Ratio	47.4%

How did SGFE.F perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

12%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/08/27 05:41
End of Day Share Price	2024/05/30 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Siegfried Holding AG is covered by 20 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Laura Lopez Pineda	Baader Helvea Equity Research
Volker Bosse	Baader Helvea Equity Research
Leonildo Delgado	Baader Helvea Equity Research